We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Efficacy of Intravenous Iron in Patients with Heart Failure with Reduced Ejection Fraction and Iron Deficiency: A Systematic Review and Meta-Analysis of Randomized Control Trials

    Background

    The European Society of Cardiology (ESC) provided a focused update to the 2021 Guideline for the Management of Heart Failure, now providing...

    Andrew Sephien, Denisse Camille Dayto, ... Ambuj Kumar in American Journal of Cardiovascular Drugs
    Article 22 March 2024
  2. Effect of Ferric Carboxymaltose Versus Low-Dose Intravenous Iron Therapy and Iron Sucrose on the Total Cost of Care in Patients with Iron Deficiency Anemia: A US Claims Database Analysis

    Background and Objective

    Iron deficiency is the most common cause of anemia. We compared the effect of ferric carboxymaltose (FCM), low-dose...

    Winghan Jacqueline Kwong, Kevin Wang, ... Ralph Boccia in Drugs - Real World Outcomes
    Article Open access 19 March 2024
  3. Intravenous iron and erythropoietin therapy for postoperative anemia among orthopedic surgery patients

    Background

    Postoperative anemia is a risk factor for adverse surgical outcomes. Our study aimed to assess the role of intravenous iron and...

    Huixin Chen, **g Yu, ... Shun Wang in Journal of Orthopaedic Surgery and Research
    Article Open access 18 July 2023
  4. A case of intravenous iron administration resulting in cerebral edema expansion

    Background

    Iron plays an important role in the development of perihematomal edema (PHE) in the setting of intracerebral hemorrhage (ICH). Cerebral...

    Jonathan Espinosa, Umair Rehman, Firas Kaddouh in BMC Neurology
    Article Open access 30 May 2023
  5. Cardiopulmonary exercise testing before and after intravenous iron in preoperative patients: a prospective clinical study

    Background

    Anemia is associated with impaired physical performance and adverse perioperative outcomes. Iron-deficiency anemia is increasingly treated...

    James O. M. Plumb, James M. Otto, ... Denny Z. Levett in Perioperative Medicine
    Article Open access 03 July 2023
  6. Oral and intravenous iron treatment alter the gut microbiome differentially in dialysis patients

    Objective

    Chronic kidney disease (CKD) is often complicated by anemia, which seriously affects the quality-of-life and prognosis of patients. These...

    Huan Liu, Wenqi Wu, Yankun Luo in International Urology and Nephrology
    Article Open access 27 September 2022
  7. Safety, pharmacokinetics, and pharmacodynamics of intravenous ferric carboxymaltose in children with iron deficiency anemia

    Background

    Iron deficiency is the primary cause of anemia in children. Intravenous (IV) iron formulations circumvent malabsorption and rapidly restore...

    Bartosz Korczowski, Colm Farrell, ... Trudy Rodgers in Pediatric Research
    Article Open access 19 May 2023
  8. Intravenous iron versus blood transfusion for postpartum anemia: a systematic review and meta-analysis

    Background

    Intravenous iron (IV-iron) is used as an alternative to, or alongside, red blood cell transfusion (RBC-T) to treat more severe postpartum...

    E. Caljé, K. M. Groom, ... V. Jordan in Systematic Reviews
    Article Open access 02 January 2024
  9. Comparison of different intravenous iron preparations in terms of total oxidant and total antioxidant status, single center data

    Iron deficiency anemia is the most common and preventable cause of anemia. Oral and parenteral iron preparations can be used for treatment. There are...

    Ferda Can, Keziban Naz Yılmaz, ... Tekin Güney in Annals of Hematology
    Article 11 July 2023
  10. Hypophosphatemia attenuates improvements in vitality after intravenous iron treatment in patients with inflammatory bowel disease

    Purpose

    Iron deficiency anemia is common in people with inflammatory bowel disease (IBD), causing deterioration in quality of life, which can be...

    J. B. Bjorner, N. Kennedy, ... R. F. Pollock in Quality of Life Research
    Article Open access 14 June 2024
  11. Intravenous ferric derisomaltose versus oral iron for persistent iron deficient pregnant women: a randomised controlled trial

    Purpose

    To compare the efficacy of intravenous (IV) iron (ferric derisomaltose) with oral iron (ferrous fumarate) in women 14–21 weeks pregnant with...

    Rebecka Hansen, Veronika Markova Sommer, ... Charlotte Holm in Archives of Gynecology and Obstetrics
    Article Open access 15 September 2022
  12. What we should consider to facilitate recovery of the hematological profile in all patients after pancreaticoduodenectomy: the role of preoperative intravenous iron treatment

    Background

    In pancreaticoduodenectomy (PD), the duodenum and upper jejunum responsible for iron absorption are removed, which can lead to massive...

    Eun Young Kim, Sung Eun Park, Tae Ho Hong in BMC Surgery
    Article Open access 12 October 2023
  13. Intravenous versus oral iron for iron deficiency anaemia in pregnant Nigerian women (IVON): study protocol for a randomised hybrid effectiveness-implementation trial

    Background

    Anaemia in pregnancy is highly prevalent in African countries. High-dose oral iron is the current recommended treatment for...

    Bosede B. Afolabi, Ochuwa A. Babah, ... Nadia A. Sam-Agudu in Trials
    Article Open access 08 September 2022
  14. Intravenous ferric carboxymaltose for the management of iron deficiency and iron deficiency anaemia in children and adolescents: a review

    Iron deficiency is the primary cause of anaemia worldwide and is particularly common among children and adolescents. Intravenous (IV) iron therapy is...

    Aysegül Aksan, Fred Zepp, ... Jürgen Stein in European Journal of Pediatrics
    Article Open access 02 September 2022
  15. A randomized, controlled, open label non-inferiority trial of intravenous ferric carboxymaltose versus iron sucrose in patients with iron deficiency anemia in China

    Iron deficiency (ID) and ID anemia (IDA) pose significant public health concerns in China. Although iron sucrose (IS) treatment is well-established...

    Jie **, Zhihua Ran, ... Udo Michael Göring in Frontiers of Medicine
    Article 28 October 2023
  16. Efficacy of immediate postoperative intravenous iron supplementation after staged bilateral total knee arthroplasty

    Background

    Approximately 26% of patients undergoing major orthopedic elective procedures have preoperative anemia. This study aimed to investigate the...

    Sung-Sahn Lee, Jeounghun Lee, Young-Wan Moon in BMC Musculoskeletal Disorders
    Article Open access 07 January 2023
  17. High-Dose Intravenous Iron with Either Ferric Carboxymaltose or Ferric Derisomaltose: A Benefit-Risk Assessment

    The intravenous iron formulations ferric carboxymaltose (FCM) and ferric derisomaltose (FDI) offer the possibility of administering a large amount of...

    Johannes M. M. Boots, Rogier A. M. Quax in Drug Safety
    Article Open access 06 September 2022
  18. The Efficacy and Safety of Intravenous Iron in Geriatric Hip Fracture Surgeries: A Systematic Review and Meta-Analysis

    Background

    With the increasing evidence provided by recent high-quality studies, the intravenous iron appears to be a reliable therapy for blood...

    Mu-Min Cao, Jia-Yu Chi, ... Yun-Feng Rui in World Journal of Surgery
    Article 10 August 2022
  19. Impact of postoperative intravenous iron therapy on postoperative infections in older patients with severe anaemia after hip fracture surgery

    Background

    Anaemia is common following hip fracture in ortho-geriatric patients and is associated with postoperative infections.. This study...

    Lene T. Hansen, Johannes Riis, ... Dorte Melgaard in BMC Geriatrics
    Article Open access 14 February 2023
  20. Incidence of Hypophosphatemia After Intravenous Administration of Iron: A Matching-Adjusted Indirect Comparison of Data from Japanese Randomized Controlled Trials

    Introduction

    Intravenous (IV) administration of iron is considered a safe and efficacious treatment for iron deficiency anemia (IDA), recommended in...

    Seiji Fukumoto, Tatsunori Murata, ... Richard F. Pollock in Advances in Therapy
    Article Open access 13 September 2023
Did you find what you were looking for? Share feedback.